Early research (Phase 1)Not Yet RecruitingNCT07100925
What this trial is testing
Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma
Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)Renal TransplantSolid Tumor+1 more
Ankyra Therapeutics, Inc 20